PRMTs and miRNAs: functional cooperation in cancer and beyond

Date
2019-06-24
Language
American English
Embargo Lift Date
Committee Members
Degree
Degree Year
Department
Grantor
Journal Title
Journal ISSN
Volume Title
Found At
Taylor & Francis
Abstract

Epigenetic modulators play pivotal roles in directing gene expression for the maintenance of normal cellular functions. However, when these modulators are aberrantly regulated, this can result in a variety of disease states, including cancer. One class of epigenetic regulators, protein arginine methyltransferases (PRMTs), have been shown to play critical roles in disease through methylation of arginine residues (R) on histone or non-histone proteins. Quite different from PRMTs, microRNAs (miRNAs) belong to the family of modulators known as noncoding RNAs (ncRNA) that act to regulate gene expression via RNA-mediated gene silencing. Importantly, miRNAs are frequently dysregulated and contribute to the progression of cancer and other conditions, including neurological and cardiovascular diseases. Recently, numerous studies have shown that miRNAs and other epigenetic enzymes can co-regulate each other. This review highlights multiple nodes of interaction between miRNAs and PRMTs and also discusses how this interplay might open up promising opportunities for drug development for the treatment of cancer and other diseases.

Description
item.page.description.tableofcontents
item.page.relation.haspart
Cite As
Jin, J., Martin, M., Hartley, A.-V., & Lu, T. (2019). PRMTs and miRNAs: Functional cooperation in cancer and beyond. Cell Cycle, 18(15), 1676–1686. https://doi.org/10.1080/15384101.2019.1629791
ISSN
1538-4101
Publisher
Series/Report
Sponsorship
Major
Extent
Identifier
Relation
Journal
Cell Cycle
Rights
Source
PMC
Alternative Title
Type
Article
Number
Volume
Conference Dates
Conference Host
Conference Location
Conference Name
Conference Panel
Conference Secretariat Location
Version
This item is under embargo {{howLong}}